The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Homogeneity of active demyelinating lesions in established multiple sclerosis
Abstract
Objective: Four different patterns of demyelination have been described in active demyelinating lesions of multiple sclerosis (MS) patients that were biopsied shortly after disease onset. These patterns were suggested to represent heterogeneity of the underlying pathogenesis. The aim of this study was to determine whether lesion heterogeneity also exists in an unselected collection of autopsy material from patients with established MS. Methods: All MS brain tissue available in the VU Medical Center was assessed for the presence of active demyelinating lesions using magnetic resonance imaging–guided sampling and immunohistochemistry. Tissue blocks containing active demyelinating lesions were evaluated for the presence of complement and antibody deposition, oligodendrocyte apoptosis, differential loss of myelin proteins, and hypoxia‐like damage using histology, immunohistochemistry, and confocal microscopy. Blocks with active demyelinating lesions were compared with blocks with active (nondemyelinating) and inactive lesions. Results: Complement and antibodies were consistently associated with macrophages in areas of active demyelination. Preferential loss of myelin proteins, extensive hypoxia‐like damage, and oligodendrocyte apoptosis were absent or rare. This pattern was observed in all tissue blocks containing active demyelinating lesions; lesion heterogeneity between patients was not found. Interpretation: The immunopathological appearance of active demyelinating lesions in established MS is uniform. Initial heterogeneity of demyelinating lesions in the earliest phase of MS lesion formation may disappear over time as different pathways converge in one general mechanism of demyelination. Consistent presence of complement, antibodies, and Fcγ receptors in phagocytic macrophages suggests that antibody‐ and complement‐mediated myelin phagocytosis is the dominant mechanism of demyelination in established MS. Ann Neurol 2008;63:16–25
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Handbook of Clinical Neurology: 3. Disorders of Higher Nervous Activity
LANDAU, W. M. (1970) · Neurology · doi:10.1212/wnl.20.12.1223-a · Cited by 961
Identification of autoantibodies associated with myelin damage in multiple sclerosis
Genain, C. P., Cannella, B., Hauser, S. L., & Raine, C. S. (1999) · Nature Medicine · doi:10.1038/5532 · Cited by 892
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757 · cited 1×
“Predilection sites are optic nerve, periventricular white matter, subpial cerebral cortex, brainstem, and cervical spinal cord.(1,2) MS is a heterogeneous disease with a broad spectrum of interindividual differences in clinical presentation, location and frequency of lesions, serological abnormalities, and response to…”
BackgroundSelf-citationImmunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422
Nijeholt, G. (1998) · Brain · doi:10.1093/brain/121.4.687 · Cited by 381
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects
Morgan, B. P. (1989) · Biochemical Journal · doi:10.1042/bj2640001 · Cited by 380
Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Brück, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K., & Lassmann, H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.25 · Cited by 330
Piddlesden, S. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90424-6 · Cited by 287
Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
Prineas, J. W., & Graham, J. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100205 · Cited by 264
Bö, L., Mörk, S., Kong, P. A., Nyland, H., Pardo, C. A., & Trapp, B. D. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90075-2 · Cited by 256
Self-citationBiological markers in CSF and blood for axonal degeneration in multiple sclerosis
Teunissen, C. E., Dijkstra, C., & Polman, C. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00964-0 · Cited by 252
Self-citationLassmann, H., Raine, C. S., Antel, J., & Prineas, J. W. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00031-9 · Cited by 250
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement
Scolding, N. J., Morgan, B. P., Houston, W. A. J., Linington, C., Campbell, A. K., & Compston, D. A. S. (1989) · Nature · doi:10.1038/339620a0 · Cited by 245
Itoyama, Y., Sterhberger, N. H., Webster, H. D., Quarles, R. H., Cohen, S. R., & Richardson, E. P. (1980) · Annals of Neurology · doi:10.1002/ana.410070212 · Cited by 241
Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis
Stadelmann, C., Ludwin, S., Tabira, T., Guseo, A., Lucchinetti, C. F., Leel-Össy, L., Ordinario, A. T., Brück, W., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh457 · Cited by 234
Zhou, D., Srivastava, R., Nessler, S., Grummel, V., Sommer, N., Brück, W., Hartung, H.-P., Stadelmann, C., & Hemmer, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607242103 · Cited by 231
Bonetti, B., & Raine, C. S. (1997) · Annals of Neurology · doi:10.1002/ana.410420113 · Cited by 207
Brink, B. P., Veerhuis, R., Breij, E. C. W., van der Valk, P., Dijkstra, C. D., & Bö, L. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.147 · Cited by 191
Self-citationUlvestad, E., Williams, K., Vedeler, C., Antel, J., Nyland, H., Mørk, S., & Matre, R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90340-9 · Cited by 167
Piddlesden, S. J., Lassmann, H., Zimprich, F., Morgan, B. P., & Linington, C. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)91046-f · Cited by 137
The pathology of multiple sclerosis: a paradigm shift
Barnett, M. H., & Sutton, I. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000227032.47458.cb · Cited by 113
Kuhlmann, T., Remington, L. T., Maruschak, B., Owens, T., & Brück, W. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000248559.83573.71 · Cited by 98
Pittock, S. J., McClelland, R. L., Achenbach, S. J., Konig, F., Bitsch, A., Brück, W., Lassmann, H., Parisi, J. E., Scheithauer, B. W., Rodriguez, M., et al. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.060624 · Cited by 89
Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis
Epstein, L. G., Prineas, J. W., & Raine, C. S. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90167-3 · Cited by 83
Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis
Bø, L., Geurts, J. J. G., Ravid, R., & Barkhof, F. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2003.00521.x · Cited by 72
Self-citationMultiple sclerosis complexity in selected populations: the challenge of Sardinia, insular Italy1
Sotgiu, S., Pugliatti, M., Sanna, A., Sotgiu, A., Castiglia, P., Solinas, G., Dolei, A., Serra, C., Bonetti, B., & Rosati, G. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00412.x · Cited by 59
The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages
van der Goes, A., Kortekaas, M. C., Hoekstra, K., Dijkstra, C. D., & Amor, S. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00133-2 · Cited by 55
Self-citationSchwab, C., & McGeer, P. L. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7851 · Cited by 51
Determination of the sequential degradation of myelin proteins by macrophages
van der Goes, A., Boorsma, W., Hoekstra, K., Montagne, L., Groot, C. J. A. D., & Dijkstra, C. D. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.12.010 · Cited by 38
Self-citationCurrent trials in multiple sclerosis: established evidence and future hopes
Killestein, J., & Polman, C. H. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169741.29535.cc · Cited by 26
Breij, E. C. W., Heijnen, P. D. A. M., van der Goes, A., Teunissen, C. E., Polman, C. H., & Dijkstra, C. D. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.014 · Cited by 13
Self-citationDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
Absinta, M., Maric, D., Gharagozloo, M., Garton, T., Smith, M. D., Jin, J., Fitzgerald, K. C., Song, A., Liu, P., Lin, J.-P., et al. (2021) · Nature · doi:10.1038/s41586-021-03892-7 · Cited by 768
Frischer, J. M., Weigand, S. D., Guo, Y., Kale, N., Parisi, J. E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24497 · Cited by 728
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Metadata
- Authors
- Breij, E. C. W., Brink, B. P., Veerhuis, R., van den Berg, C., Vloet, R., Yan, R., Dijkstra, C. D., van der Valk, P., & Bö, L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 63
- Issue
- 1
- Pages
- 16-25
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1975434091
- Cited by
- 353
- References
- 34
- FWCI
- 22.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.